http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2454181-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2a405c85c98413b715c5ddef6cba19f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
filingDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c3727fe8dffd40aa7da7692c0726e28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ab81350eb2c4f4867ea047429a4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc7ee2877b29faafbf19e3ddabb7406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53cadcbb8ef525a6e5c1f3bba2984fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba3fe604935915f549c0c289e7f184a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce597fcc184b9516f1335ebab53c424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a304dcd783d3fcd42f6932a5e979b129
publicationDate 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2454181-C1
titleOfInvention Method of diagnosing stage of urinary bladder cancer invasion
abstract FIELD: medicine. n SUBSTANCE: invention relates to field of medicine, namely to urology and oncology. In order to diagnose stage of urinary bladder cancer invasion UBC-antigen of urinary bladder cancer, representing soluble fragment of cytokeratins 8 and 18, is determined in patient's urine. If its value is higher than 22.5 mcg/ml, TPS-tissue polypeptide spherical, which represents fragment of cytokeratin 18, is determined in blood serum. If TPS value is 61.5-106.93 Units/l, muscular-non-invasive urinary bladder cancer is diagnosed. If TPS value is 106.94-181.29 Units/l, invasive urinary bladder cancer within the organ is diagnosed. If TPS value is higher than 181.29 Units/l, outlet of tumour beyond the organ is diagnosed. n EFFECT: method makes it possible to diagnose stages of urinary bladder cancer invasion with high accuracy. n 3 ex, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2785737-C2
priorityDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008111496-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136778
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05783
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO57611
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5BJY9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7ZTS4
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6P864
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07427
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5K2N9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7SYF8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO57607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05784

Total number of triples: 35.